Download PDF
Vet Comp Orthop Traumatol 2019; 32(03): 173-181
DOI: 10.1055/s-0039-1678547
Original Research
Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Intravenously Delivered Allogeneic Mesenchymal Stem Cells for Treatment of Elbow Osteoarthritis in Dogs: A Pilot Study

Anastasia Olsen
1   Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
,
Valerie Johnson
1   Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
2   Center for Immune and Regenerative Medicine, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado, United States
,
Tracy Webb
1   Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
2   Center for Immune and Regenerative Medicine, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado, United States
,
Kelly S. Santangelo
3   Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
,
Steven Dow
1   Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
2   Center for Immune and Regenerative Medicine, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado, United States
,
Felix M. Duerr
1   Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States
› Author Affiliations
Further Information

Publication History

16 June 2018

11 December 2018

Publication Date:
14 March 2019 (online)

   Permissions and Reprints

Abstract

Objectives The aim of this study was to evaluate the safety and collect pilot data measuring clinical effects of intravenously administered, adipose-derived, culture-expanded, allogeneic mesenchymal stem cells in dogs with elbow osteoarthritis.

Materials and Methods Dogs (n = 13) with naturally occurring elbow osteoarthritis received three intravenous doses of allogeneic canine mesenchymal stem cells via an open-label clinical trial. Primary outcome measures collected over a 6-month study period included objective gait analysis, accelerometry, owner questionnaires and joint fluid analysis.

Results No acute adverse events were observed following repeated intravenous treatment with allogeneic mesenchymal stem cells. A significant improvement in mean client-specific outcome measure (CSOM) activity score and CSOM behaviour score was observed when pre-treatment values were compared with post-treatment values (day >28). In contrast, mean peak vertical force significantly decreased from baseline to post-treatment (>day 28). Weekly activity counts did not show a significant difference between baseline to post-treatment time points. Synovial fluid biomarkers did not change during treatment, and labelled mesenchymal stem cells were rarely detected in synovial fluid samples collected after mesenchymal stem cell administration.

Clinical Significance For dogs with naturally occurring elbow osteoarthritis, intravenous administration of mesenchymal stem cells was clinically well tolerated. While some subjective outcome measures showed significant improvements, objective outcome measures did not confirm similar changes. Further research is needed before intravenous mesenchymal stem cells can be recommended as a treatment for elbow osteoarthritis in dogs.

Keywords

cartilage degeneration - cell-based therapies - clinical lameness - degenerative joint disease - elbow osteoarthritis

Author Contribution

All authors contributed to conception of study, study design, acquisition of data, and data analysis and interpretation. All authors also drafted, revised and approved the submitted manuscript.


Supplementary Material

 

  • References

  • 1 Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician 2012; 85 (01) 49-56
    PubMedGoogle Scholar
  • 2 Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46 (03) 704-713
    CrossrefPubMedGoogle Scholar
  • 3 Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002; 39 (1-2): 237-246
    PubMedGoogle Scholar
  • 4 Malek S, Sample SJ, Schwartz Z. , et al. Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Vet Res 2012; 8: 185
    CrossrefPubMedGoogle Scholar
  • 5 Griffin MD, Ritter T, Mahon BP. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010; 21 (12) 1641-1655
    CrossrefPubMedGoogle Scholar
  • 6 Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009; 27 (12) 1675-1680
    CrossrefPubMedGoogle Scholar
  • 7 Freitag J, Bates D, Boyd R. , et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review. BMC Musculoskelet Disord 2016; 17: 230
    CrossrefPubMedGoogle Scholar
  • 8 Whitworth DJ, Banks TA. Stem cell therapies for treating osteoarthritis: prescient or premature?. Vet J 2014; 202 (03) 416-424
    CrossrefPubMedGoogle Scholar
  • 9 Black LL, Gaynor J, Adams C. , et al. Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 2008; 9 (03) 192-200
    Google Scholar
  • 10 Kiefer KM, Conzemius M, Pluhar GE. The development and use of canine adipose derived stromal and progenitor cells to treat osteoarthritis [dissertation]. St. Paul: University of Minnesota; 2013: 93
    Google Scholar
  • 11 Vilar JM, Batista M, Morales M. , et al. Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis. BMC Vet Res 2014; 10: 143
    CrossrefPubMedGoogle Scholar
  • 12 Kiefer KM, O'Brien TD, Pluhar EG, Conzemius M. Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints. Vet Rec Open 2015; 2 (01) e000063
    CrossrefPubMedGoogle Scholar
  • 13 Zhang J, Huang X, Wang H. , et al. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Res Ther 2015; 6: 234
    CrossrefPubMedGoogle Scholar
  • 14 Li F, Niyibizi C. Engraftability of murine bone marrow-derived multipotent mesenchymal stem cell subpopulations in the tissues of developing mice following systemic transplantation. Cells Tissues Organs 2016; 201 (01) 14-25
    CrossrefPubMedGoogle Scholar
  • 15 Quimby JM, Webb TL, Randall E, Marolf A, Valdes-Martinez A, Dow SW. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats. J Feline Med Surg 2016; 18 (02) 165-171
    CrossrefPubMedGoogle Scholar
  • 16 Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther 2013; 4 (02) 48
    CrossrefPubMedGoogle Scholar
  • 17 Brown DC, Bell M, Rhodes L. Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis. Am J Vet Res 2013; 74 (12) 1467-1473
    CrossrefPubMedGoogle Scholar
  • 18 Johnson V, Webb T, Norman A. , et al. Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections. Sci Rep 2017; 7 (01) 9575
    CrossrefPubMedGoogle Scholar
  • 19 L Ramos T, Sánchez-Abarca LI, Muntión S. , et al. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Commun Signal 2016; 14: 2
    CrossrefPubMedGoogle Scholar
  • 20 Chow L, Johnson V, Regan D. , et al. Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells. Stem Cell Res (Amst) 2017; 25: 221-232
    CrossrefPubMedGoogle Scholar
  • 21 Belshaw Z, Asher L, Dean RS. Systematic review of outcome measures reported in clinical canine osteoarthritis research. Vet Surg 2016; 45 (04) 480-487
    CrossrefPubMedGoogle Scholar
  • 22 Besancon MF, Conzemius MG, Derrick TR. , et al. Comparison of vertical forces in normal greyhounds between force platform and pressure walkway measurement systems. Vet Comp Orthop Traumatol 2003; 16: 153-157
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Kim J, Kazmierczak KA, Breur GJ. Comparison of temporospatial and kinetic variables of walking in small and large dogs on a pressure-sensing walkway. Am J Vet Res 2011; 72 (09) 1171-1177
    CrossrefPubMedGoogle Scholar
  • 24 Horstman CL, Conzemius MG, Evans R, Gordon WJ. Assessing the efficacy of perioperative oral carprofen after cranial cruciate surgery using noninvasive, objective pressure platform gait analysis. Vet Surg 2004; 33 (03) 286-292
    CrossrefPubMedGoogle Scholar
  • 25 Hansen BD, Lascelles BD, Keene BW, Adams AK, Thomson AE. Evaluation of an accelerometer for at-home monitoring of spontaneous activity in dogs. Am J Vet Res 2007; 68 (05) 468-475
    CrossrefPubMedGoogle Scholar
  • 26 Almaawi A, Wang HT, Ciobanu O. , et al. Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells. Tissue Eng Part A 2013; 19 (7-8): 1039-1046
    CrossrefPubMedGoogle Scholar
  • 27 Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 2003; 152 (11) 323-329
    CrossrefPubMedGoogle Scholar
  • 28 Hans EC, Zwarthoed B, Seliski J, Nemke B, Muir P. Variance associated with subject velocity and trial repetition during force platform gait analysis in a heterogeneous population of clinically normal dogs. Vet J 2014; 202 (03) 498-502
    CrossrefPubMedGoogle Scholar
  • 29 Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis. J Am Vet Med Assoc 2012; 241 (10) 1314-1319
    CrossrefPubMedGoogle Scholar
  • 30 Fortier LA. Stem cells: classifications, controversies, and clinical applications. Vet Surg 2005; 34 (05) 415-423
    CrossrefPubMedGoogle Scholar
  • 31 Nagaya N, Fujii T, Iwase T. , et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004; 287 (06) H2670-H2676
    CrossrefPubMedGoogle Scholar
  • 32 Kim Y, Jo SH, Kim WH, Kweon OK. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther 2015; 6: 229
    CrossrefPubMedGoogle Scholar
  • 33 Petchdee S, Sompeewong S. Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease. Vet World 2016; 9 (12) 1429-1434
    CrossrefPubMedGoogle Scholar
  • 34 Askari AT, Unzek S, Popovic ZB. , et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362 (9385): 697-703
    CrossrefPubMedGoogle Scholar
  • 35 Wang L, Li Y, Chen X. , et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002; 7 (02) 113-117
    CrossrefPubMedGoogle Scholar
  • 36 Fernandez-Pernas P, Rodríguez-Lesende I, de la Fuente A. , et al. CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model. PLoS One 2017; 12 (11) e0188072
    CrossrefPubMedGoogle Scholar
  • 37 Favero M, El-Hadi H, Belluzzi E. , et al. Infrapatellar fat pad features in osteoarthritis: a histopathological and molecular study. Rheumatology (Oxford) 2017; 56 (10) 1784-1793
    CrossrefPubMedGoogle Scholar
  • 38 Spriet M, Hunt GB, Walker NJ, Borjesson DL. Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs. Vet Radiol Ultrasound 2015; 56 (03) 327-334
    CrossrefPubMedGoogle Scholar
  • 39 Fischer UM, Harting MT, Jimenez F. , et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009; 18 (05) 683-692
    CrossrefPubMedGoogle Scholar
  • 40 Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R. A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. Int Orthop 2016; 40 (08) 1755-1765
    CrossrefPubMedGoogle Scholar
  • 41 Aanstoos ME, Regan DP, Rose RJ, Chubb LS, Ehrhart NP. Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model?. Clin Orthop Relat Res 2016; 474 (03) 707-715
    CrossrefPubMedGoogle Scholar